As communicated on January 21, 2020, CTS will implement the licensed Grifols Babesia test for samples received on April 20, at the Charlotte, Dallas, Phoenix, St. Louis and Tampa laboratories. Babesia is a selective pooled NAT test, required for all blood donations collected by May 2020, in 14 States and the District of Columbia. To help you understand the requirements, CTS will host a Babesia Implementation and Review webinar on March 3, 2020 at 11:00 am CST. If you are interested in attending, please contact your Customer Service Manager for invitation details.
FDA Guidance titled “Further Testing of Donations that are Reactive on a Licensed Donor Screen...
On Wednesday August 15, 2018 at 11:00AM PDT, we will be hosting a webinar regarding the changes to F...
CTS will be revising some forms in use by clients on October 26, 2020. We do try to limit form chang...
As a friendly reminder, airlines often change their routine flights and cargo hours for holidays. We...
We received an updated WNV package insert; please note the manufacturer and license number has been ...